Top

Journal of Orthopaedic Surgery and Research

Published in:

Open Access 01-12-2024 | McCune-Albright syndrome | Review

Recent research advances in pain mechanisms in McCune–Albright syndrome thinking about the pain mechanism of FD/MAS

Authors: Yong Wang, Tao Jiang

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2024

Abstract

Background

The lack of effective understanding of the pain mechanism of McCune–Albright syndrome (MAS) has made the treatment of pain in this disease a difficult clinical challenge, and new therapeutic targets are urgently needed to address this dilemma.

Objective

This paper summarizes the novel mechanisms, targets, and treatments that may produce pain in MAS and fibrous dysplasia (polyfibrous dysplasia, or FD).

Methods

We conducted a systematic search in the PubMed database, Web of Science, China Knowledge Network (CNKI) with the following keywords: “McCune–Albright syndrome (MAS); polyfibrous dysplasia (FD); bone pain; bone remodeling; G protein coupled receptors; GDNF family receptors; purinergic receptors and glycogen synthase kinase”, as well as other keywords were systematically searched. Papers published between January 2018 and May 2023 were selected for finding. Initial screening was performed by reading the titles and abstracts, and available literature was screened against the inclusion and exclusion criteria.

Results

In this review, we systematically analyzed the cutting-edge advances in this disease, synthesized the findings, and discussed the differences. With regard to the complete mechanistic understanding of the pain condition in FD/MAS, in particular, we collated new findings on new pathways, neurotrophic factor receptors, purinergic receptors, interferon-stimulating factors, potassium channels, protein kinases, and corresponding hormonal modulation and their respective strengths and weaknesses.

Conclusion

This paper focuses on basic research to explore FD/MAS pain mechanisms. New nonneuronal and molecular mechanisms, mechanically loaded responsive neurons, and new targets for potential clinical interventions are future research directions, and a large number of animal experiments, tissue engineering techniques, and clinical trials are still needed to verify the effectiveness of the targets in the future.

Tucker-Bartley A, Selen DJ, Golden E, van Gool R, Ebb D, Mannstadt M, Upadhyay J. Pharmacological interventions targeting pain in fibrous dysplasia/McCune-Albright syndrome. Int J Mol Sci. 2023;24(3):2550. https://doi.org/10.3390/ijms24032550.PMID:36768871;PMCID:PMC9916440.CrossRefPubMedPubMedCentral

Zeng BH. Current status of diagnosis and treatment of McCune-Albright syndrome. Med Rev. 2016;22(22):4475–9.

Jiang X, Li Y. Advances in the study of McCune-Albright syndrome in children. Chin J Pediatr Surg. 2015;36(12):956–60.

Golden E, Zhang F, Selen DJ, Ebb D, Romo L, Drubach LA, Shah N, O’Donnell LJ, Lemme JD, Myers R, Cay M, Kronenberg HM, Westin CF, Boyce AM, Kaban LB, Upadhyay J. Case report: the imperfect association between craniofacial lesion burden and pain in fibrous dysplasia. Front Neurol. 2022;16(13): 855157. https://doi.org/10.3389/fneur.2022.855157.PMID:35370900;PMCID:PMC8966612.CrossRef

Chapurlat RD, Gensburger D, Jimenez-Andrade JM, Ghilardi JR, Kelly M, Mantyh P. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis. 2012;7(Suppl 1):S3. https://doi.org/10.1186/1750-1172-7-S1-S3.CrossRefPubMedPubMedCentral

Hendrickx G, Fischer V, Liedert A, von Kroge S, Haffner-Luntzer M, Brylka L, Pawlus E, Schweizer M, Yorgan T, Baranowsky A, Rolvien T, Neven M, Schumacher U, Beech DJ, Amling M, Ignatius A, Schinke T. Piezo1 inactivation in chondrocytes impairs trabecular bone formation. J Bone Miner Res. 2021;36(2):369–84. https://doi.org/10.1002/jbmr.4198. (Epub 2020 Nov 12 PMID: 33180356).CrossRefPubMed

Wang L, You X, Lotinun S, Zhang L, Wu N, Zou W. Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk. Nat Commun. 2020;11(1):282. https://doi.org/10.1038/s41467-019-14146-6.PMID:31941964;PMCID:PMC6962448.CrossRefPubMedPubMedCentral

Sasaki F, Hayashi M, Mouri Y, Nakamura S, Adachi T, Nakashima T. Mechanotransduction via the Piezo1-Akt pathway underlies Sost suppression in osteocytes. Biochem Biophys Res Commun. 2020;521(3):806–13. https://doi.org/10.1016/j.bbrc.2019.10.174. (Epub 2019 Nov 8 PMID: 31708103).CrossRefPubMed

Sonkodi B. Miswired proprioception in amyotrophic lateral sclerosis in relation to pain sensation (and in delayed onset muscle soreness)-Is Piezo2 channelopathy a principal transcription activator in proprioceptive terminals besides being the potential primary damage? Life. 2023;13(3):657. https://doi.org/10.3390/life13030657.PMID:36983813;PMCID:PMC10053310.CrossRefPubMedPubMedCentral

10.

Szczot M, Liljencrantz J, Ghitani N, Barik A, Lam R, Thompson JH, Bharucha-Goebel D, Saade D, Necaise A, Donkervoort S, Foley AR, Gordon T, Case L, Bushnell MC, Bönnemann CG, Chesler AT. PIEZO2 mediates injury-induced tactile pain in mice and humans. Sci Transl Med. 2018;10(462):9892. https://doi.org/10.1126/scitranslmed.aat9892.CrossRef

11.

Nagy ZF, Sonkodi B, Pál M, Klivényi P, Széll M. Likely pathogenic variants of Cav1. 3 and Nav1. 1 encoding genes in amyotrophic lateral sclerosis could elucidate the dysregulated pain pathways. Biomedicines. 2023;11(3):933. https://doi.org/10.3390/biomedicines11030933.CrossRefPubMedPubMedCentral

12.

Venugopal S, Ghulam-Jhelani Z, Ahn IS, Yang X, Wiedau M, Simmons D, Chandler SH. Early deficits in GABA inhibition parallels an increase in L-type Ca2+ currents in the jaw motor neurons of SOD1G93A mouse model for ALS. Neurobiol Dis. 2023;177: 105992. https://doi.org/10.1016/j.nbd.2023.105992. (Epub 2023 Jan 6 PMID: 36623607).CrossRefPubMed

13.

Perin M, Chinigò G, Genova T, Mussano F, Munaron L. The impact of plasma membrane ion channels on bone remodeling in response to mechanical stress, oxidative imbalance, and acidosis. Antioxidants. 2023;12(3):689. https://doi.org/10.3390/antiox12030689.PMID:36978936;PMCID:PMC10045377.CrossRefPubMedPubMedCentral

14.

Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci. 2019;20(14):3576. https://doi.org/10.3390/ijms20143576.PMID:31336616;PMCID:PMC6678498.CrossRefPubMedPubMedCentral

15.

Dizin E, Olivier V, Roth I, Sassi A, Arnoux G, Ramakrishnan S, Morel S, Kwak BR, Loffing J, Hummler E, Wenger RH, Frew IJ, Feraille E. Activation of the hypoxia-inducible factor pathway inhibits epithelial sodium channel-mediated sodium transport in collecting duct principal cells. J Am Soc Nephrol. 2021;32(12):3130–45. https://doi.org/10.1681/ASN.2021010046.CrossRefPubMedPubMedCentral

16.

Boyce AM, Kelly MH, Brillante BA, Kushner H, Wientroub S, Riminucci M, Bianco P, Robey PG, Collins MT. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab. 2014;99(11):4133–40. https://doi.org/10.1210/jc.2014-1371.CrossRefPubMedPubMedCentral

17.

Zhen G, Fu Y, Zhang C, Ford NC, Wu X, Wu Q, Yan D, Chen X, Cao X, Guan Y. Mechanisms of bone pain: progress in research from bench to bedside. Bone Res. 2022;10(1):44. https://doi.org/10.1038/s41413-022-00217-w.PMID:35668080;PMCID:PMC9170780.CrossRefPubMedPubMedCentral

18.

Koivisto AP, Belvisi MG, Gaudet R, Szallasi A. Advances in TRP channel drug discovery: from target validation to clinical studies. Nat Rev Drug Discov. 2022;21(1):41–59. https://doi.org/10.1038/s41573-021-00268-4.CrossRefPubMed

19.

Duitama M, Vargas-López V, Casas Z, Albarracin SL, Sutachan JJ, Torres YP. TRP channels role in pain associated with neurodegenerative diseases. Front Neurosci. 2020;4(14):782. https://doi.org/10.3389/fnins.2020.00782.PMID:32848557;PMCID:PMC7417429.CrossRef

20.

Liu YS, Liu YA, Huang CJ, Yen MH, Tseng CT, Chien S, Lee OK. Mechanosensitive TRPM7 mediates shear stress and modulates osteogenic differentiation of mesenchymal stromal cells through osterix pathway. Sci Rep. 2015;12(5):16522. https://doi.org/10.1038/srep16522.PMID:26558702;PMCID:PMC4642269.CrossRef

21.

Son A, Kang N, Kang JY, Kim KW, Yang YM, Shin DM. TRPM3/TRPV4 regulates Ca2+-mediated RANKL/NFATc1 expression in osteoblasts. J Mol Endocrinol. 2018;61(4):207–18. https://doi.org/10.1530/JME-18-0051. (PMID: 30328352).CrossRefPubMed

22.

Corrigan MA, Johnson GP, Stavenschi E, Riffault M, Labour MN, Hoey DA. TRPV4-mediates oscillatory fluid shear mechanotransduction in mesenchymal stem cells in part via the primary cilium. Sci Rep. 2018;8(1):3824. https://doi.org/10.1038/s41598-018-22174-3.PMID:29491434;PMCID:PMC5830574.CrossRefPubMedPubMedCentral

23.

Du G, Chen W, Li L, Zhang Q. The potential role of mechanosensitive ion channels in substrate stiffness-regulated Ca2+ response in chondrocytes. Connect Tissue Res. 2022;63(5):453–62. https://doi.org/10.1080/03008207.2021.2007902. (Epub 2021 Nov 23 PMID: 34814790).CrossRefPubMed

24.

Dutta B, Arya RK, Goswami R, Alharbi MO, Sharma S, Rahaman SO. Role of macrophage TRPV4 in inflammation. Lab Invest. 2020;100(2):178–85. https://doi.org/10.1038/s41374-019-0334-6.CrossRefPubMed

25.

Liu BL, Cao QL, Zhao X, Liu HZ, Zhang YQ. Inhibition of TRPV1 by SHP-1 in nociceptive primary sensory neurons is critical in PD-L1 analgesia. JCI Insight. 2020;5(20): e137386. https://doi.org/10.1172/jci.insight.137386.PMID:32960817;PMCID:PMC7605531.CrossRefPubMedPubMedCentral

26.

Chen W, Li H, Hao X, Liu C. TRPV1 in dorsal root ganglion contributed to bone cancer pain. Front Pain Res. 2022;9(3):1022022. https://doi.org/10.3389/fpain.2022.1022022.PMID:36438444;PMCID:PMC9682177.CrossRef

27.

Wein MN, Kronenberg HM. Regulation of bone remodeling by parathyroid hormone. Cold Spring Harb Perspect Med. 2018;8(8): a031237. https://doi.org/10.1101/cshperspect.a031237.PMID:29358318;PMCID:PMC6071549.CrossRefPubMedPubMedCentral

28.

Du L, Feng R, Ge S. PTH/SDF-1α cotherapy promotes proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells. Cell Prolif. 2016;49(5):599–608. https://doi.org/10.1111/cpr.12286.CrossRefPubMedPubMedCentral

29.

Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, Patano N, Strippoli M, Vergari R, Mancini L, Colucci S, Grano M, Faccio R, Liu X, Li J, Usmani S, Bachar M, Bab I, Nishimori K, Young LJ, Buettner C, Iqbal J, Sun L, Zaidi M, Zallone A. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci USA. 2009;106(17):7149–54. https://doi.org/10.1073/pnas.0901890106.CrossRefPubMedPubMedCentral

30.

Klein GL. Insulin and bone: recent developments. World J Diabetes. 2014;5(1):14–6. https://doi.org/10.4239/wjd.v5.i1.14.PMID:24567798;PMCID:PMC3932424.CrossRefPubMedPubMedCentral

31.

Jackson E, Lara-Castillo N, Akhter MP, Dallas M, Scott JM, Ganesh T, Johnson ML. Osteocyte Wnt/β-catenin pathway activation upon mechanical loading is altered in ovariectomized mice. Bone Rep. 2021;14(15): 101129. https://doi.org/10.1016/j.bonr.2021.101129.PMID:34584905;PMCID:PMC8455641.CrossRef

32.

Manolagas SC, O’Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9(12):699–712. https://doi.org/10.1038/nrendo.2013.179.CrossRefPubMedPubMedCentral

33.

Tsiftsoglou AS. Erythropoietin (EPO) as a key regulator of erythropoiesis, bone remodeling and endothelial transdifferentiation of multipotent mesenchymal stem cells (MSCs): implications in regenerative medicine. Cells. 2021;10(8):2140. https://doi.org/10.3390/cells10082140.PMID:34440909;PMCID:PMC8391952.CrossRefPubMedPubMedCentral

34.

Tunheim EG, Skallevold HE, Rokaya D. Role of hormones in bone remodeling in the craniofacial complex: a review. J Oral Biol Craniofac Res. 2023;13(2):210–7. https://doi.org/10.1016/j.jobcr.2023.01.009.CrossRefPubMedPubMedCentral

35.

Xiaoyun Z, Hao Z, Lin M. Research progress on pain mechanism and treatment of knee osteoarthritis. Chin J Pain Med. 2023;29(01):50–8.

36.

Zhang X, Zhu L, Wang X, Xia L, Zhang Y. Advances in the role and mechanism of miRNA in inflammatory pain. Biomed Pharmacother. 2023;161: 114463. https://doi.org/10.1016/j.biopha.2023.114463. (Epub 2023 Mar 1 PMID: 36868014).CrossRefPubMed

37.

Huang YH, Su YS, Chang CJ, Sun WH. Heteromerization of G2A and OGR1 enhances proton sensitivity and proton-induced calcium signals. J Recept Signal Transduct Res. 2016;36(6):633–44. https://doi.org/10.3109/10799893.2016.1155064. (Epub 2016 Apr 6 PMID: 27049592).CrossRefPubMed

38.

Li DY, Gao SJ, Sun J, Zhang LQ, Wu JY, Song FH, Liu DQ, Zhou YQ, Mei W. Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain. Neural Regen Res. 2023;18(5):996–1003. https://doi.org/10.4103/1673-5374.355748.PMID:36254980;PMCID:PMC9827765.CrossRefPubMed

39.

Guerrero-Solano JA, Bautista M, Velázquez-González C, De la O-Arciniega M, González-Olivares LG, Fernández-Moya M, Jaramillo-Morales OA. Antinociceptive synergism of pomegranate peel extract and acetylsalicylic acid in an animal pain model. Molecules. 2021; 26(18): 5434. doi: 10. 3390/molecules26185434.

40.

Song MY, Han CY, Moon YJ, Lee JH, Bae EJ, Park BH. Sirt6 reprograms myofibers to oxidative type through CREB-dependent Sox6 suppression. Nat Commun. 2022;13(1):1808. https://doi.org/10.1038/s41467-022-29472-5.PMID:35379817;PMCID:PMC8980083.CrossRefPubMedPubMedCentral

41.

Zhang B, Zhao J, Wang Z, Xu L, Liu A, Du G. DL0410 attenuates oxidative stress and neuroinflammation via BDNF/TrkB/ERK/CREB and Nrf2/HO-1 activation. Int Immunopharmacol. 2020;86: 106729. https://doi.org/10.1016/j.intimp.2020.106729. (Epub 2020 Jul 6 PMID: 32645628).CrossRefPubMed

42.

Li J, Wang X, Wang H, Wang R, Guo Y, Xu L, Zhang G, Wu J, Wang G. The BDNF-TrkB signaling pathway in the rostral anterior cingulate cortex is involved in the development of pain aversion in rats with bone cancer via NR2B and ERK-CREB signaling. Brain Res Bull. 2022;185:18–27. https://doi.org/10.1016/j.brainresbull.2022.04.001. (Epub 2022 Apr 8 PMID: 35398541).CrossRefPubMed

43.

Sun L, Zhou J, Sun C. MicroRNA-211-5p enhances analgesic effect of dexmedetomidine on inflammatory visceral pain in rats by suppressing ERK signaling. J Mol Neurosci. 2019;68(1):19–28. https://doi.org/10.1007/s12031-019-01278-z. (Epub 2019 Mar 14 PMID: 30874971).CrossRefPubMed

44.

Wu XP, She RX, Yang YP, Xing ZM, Chen HW, Zhang YW. MicroRNA-365 alleviates morphine analgesic tolerance via the inactivation of the ERK/CREB signaling pathway by negatively targeting β-arrestin2. J Biomed Sci. 2018;25(1):10. https://doi.org/10.1186/s12929-018-0405-9.PMID:29415719;PMCID:PMC5802062.CrossRefPubMedPubMedCentral

45.

Scarpellino G, Genova T, Quarta E, Distasi C, Dionisi M, Fiorio Pla A, Munaron L. P2X purinergic receptors are multisensory detectors for micro-environmental stimuli that control migration of tumoral endothelium. Cancers. 2022;14(11):2743. https://doi.org/10.3390/cancers14112743.PMID:35681724;PMCID:PMC9179260.CrossRefPubMedPubMedCentral

46.

Tian SX, Xu T, Shi RY, Cai YQ, Wu MH, Zhen SJ, Wang W, Zhou Y, Du JY, Fang JF, Shao XM, Liu BY, Jiang YL, He XF, Fang JQ, Liang Y. Analgesic effect of electroacupuncture on bone cancer pain in rat model: the role of peripheral P2X3 receptor. Purinergic Signal. 2023;19(1):13–27. https://doi.org/10.1007/s11302-022-09861-7.CrossRefPubMed

47.

Yuan ZL, Liu XD, Zhang ZX, Li S, Tian Y, Xi K, Cai J, Yang XM, Liu M, Xing GG. Activation of GDNF-ERK-Runx1 signaling contributes to P2X3R gene transcription and bone cancer pain. iScience. 2022;25(9):104936. https://doi.org/10.1016/j.isci.2022.104936.CrossRefPubMedPubMedCentral

48.

Guedon JG, Longo G, Majuta LA, Thomspon ML, Fealk MN, Mantyh PW. Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain. Pain. 2016;157(6):1239–47. https://doi.org/10.1097/j.pain.0000000000000514.PMID:27186713;PMCID:PMC5142607.CrossRefPubMedPubMedCentral

49.

Falk S, Appel CK, Bennedbæk HB, Al-Dihaissy T, Unger A, Dinkel K, Heegaard AM. Chronic high dose P2X7 receptor inhibition exacerbates cancer-induced bone pain. Eur J Pharmacol. 2019;15(845):48–55. https://doi.org/10.1016/j.ejphar.2018.12.032. (Epub 2018 Dec 22 PMID: 30582910).CrossRef

50.

Sun BX, Peng AS, Liu PJ, Wang MJ, Ding HL, Hu YS, Kang L. Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions. Purinergic Signal. 2023;19(1):297–303. https://doi.org/10.1007/s11302-022-09879-x.CrossRefPubMed

51.

Duarte Azevedo M, Sander S, Tenenbaum L. GDNF, a neuron-derived factor upregulated in glial cells during disease. J Clin Med. 2020;9(2):456. https://doi.org/10.3390/jcm9020456.PMID:32046031;PMCID:PMC7073520.CrossRefPubMedPubMedCentral

52.

Nencini S, Ringuet M, Kim DH, Greenhill C, Ivanusic JJ. GDNF, neurturin, and artemin activate and sensitize bone afferent neurons and contribute to inflammatory bone pain. J Neurosci. 2018;38(21):4899–911.CrossRefPubMedPubMedCentral

53.

Gupta A, Chiavaccini L, Minnema LM, Chiu KW, Knazovicky D, Hash JA, Mishra SK, Lascelles BDX. Serum artemin is not correlated with sensitivity within dogs with naturally occurring osteoarthritis pain. Sci Rep. 2021;11(1):6682. https://doi.org/10.1038/s41598-021-85976-y.PMID:33758254;PMCID:PMC7988108.CrossRefPubMedPubMedCentral

54.

Messina DN, Peralta ED, Acosta CG. Glial-derived neurotrophic factor regulates the expression of TREK2 in rat primary sensory neurons leading to attenuation of axotomy-induced neuropathic pain. Exp Neurol. 2022;357: 114190. https://doi.org/10.1016/j.expneurol.2022.114190. (Epub 2022 Jul 27 PMID: 35907583).CrossRefPubMed

55.

Minnema L, Gupta A, Mishra SK, Lascelles BDX. Investigating the role of artemin and its cognate receptor, GFRα3, in osteoarthritis pain. Front Neurosci. 2022;27(16): 738976. https://doi.org/10.3389/fnins.2022.738976.PMID:35153665;PMCID:PMC8829392.CrossRef

56.

O-Sullivan I, Kc R, Singh G, Das V, Ma K, Li X, Mwale F, Votta-Velis G, Bruce B, Natarajan Anbazhagan A, van Wijnen AJ. Sensory neuron-specific deletion of tropomyosin receptor kinase A (TrkA) in mice abolishes osteoarthritis (OA) pain via NGF/TrkA intervention of peripheral sensitization. Int J Mol Sci 2022; 23(20):12076

57.

Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol Cell Biol. 2020;21(9):501–21. https://doi.org/10.1038/s41580-020-0244-x. (Epub 2020 May 18 PMID: 32424334).CrossRefPubMed

58.

Taguchi T, Mukai K, Takaya E, Shindo R. STING operation at the ER/Golgi interface. Front Immunol. 2021;3(12): 646304. https://doi.org/10.3389/fimmu.2021.646304.PMID:34012437;PMCID:PMC8126659.CrossRef

59.

Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21(9):548–69. https://doi.org/10.1038/s41577-021-00524-z.CrossRefPubMedPubMedCentral

60.

Liu M, Cheng X, Yan H, Chen J, Liu C, Chen Z. MiR-135-5p alleviates bone cancer pain by regulating astrocyte-mediated neuroinflammation in spinal cord through JAK2/STAT3 signaling pathway. Mol Neurobiol. 2021;58(10):4802–15. https://doi.org/10.1007/s12035-021-02458-y. (Epub 2021 Jun 27 PMID: 34176097).CrossRefPubMed

61.

Zhang Y, Wang W, Gong Z, Peng Y, Li X, Zhang Z, Zhang X, You X, Wu J. Activation of the STING pathway induces peripheral sensitization via neuroinflammation in a rat model of bone cancer pain. Inflamm Res. 2023;72(1):117–32. https://doi.org/10.1007/s00011-022-01663-2.CrossRefPubMed

62.

Lawson K. What is the progress of experimental drug development for fibromyalgia? Expert Opin Investig Drugs. 2023;32(7):563–5. https://doi.org/10.1080/13543784.2023.2230118.CrossRefPubMed

63.

Lawson K. Identification of the involvement of potassium channels in fibromyalgia. Front Biosci. 2022;14(4):29. https://doi.org/10.31083/j.fbs1404029. (PMID: 36575839).CrossRef

64.

Turner TN, Sharma K, Oh EC, Liu YP, Collins RL, Sosa MX, Auer DR, Brand H, Sanders SJ, Moreno-De-Luca D, Pihur V, Plona T, Pike K, Soppet DR, Smith MW, Cheung SW, Martin CL, State MW, Talkowski ME, Cook E, Huganir R, Katsanis N, Chakravarti A. Loss of δ-catenin function in severe autism. Nature. 2015;520(7545):51–6. https://doi.org/10.1038/nature14186.CrossRefPubMedPubMedCentral

65.

Arioka M, Takahashi-Yanaga F. Glycogen synthase kinase-3 inhibitor as a multi-targeting anti-rheumatoid drug. Biochem Pharmacol. 2019;165:207–13. https://doi.org/10.1016/j.bcp.2019.02.020. (Epub 2019 Feb 15 PMID: 30776323).CrossRefPubMed

Title: Recent research advances in pain mechanisms in McCune–Albright syndrome thinking about the pain mechanism of FD/MAS
Authors: Yong Wang
Tao Jiang
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: McCune-Albright syndrome
Published in: Journal of Orthopaedic Surgery and Research / Issue 1/2024
Electronic ISSN: 1749-799X
DOI: https://doi.org/10.1186/s13018-024-04687-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Recent research advances in pain mechanisms in McCune–Albright syndrome thinking about the pain mechanism of FD/MAS

Abstract

Background

Objective

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2024

Circ_0006640 transferred by bone marrow-mesenchymal stem cell-exosomes suppresses lipopolysaccharide-induced apoptotic, inflammatory and oxidative injury in spinal cord injury

Comparative study on the technique and efficacy of microscope-assisted MI-TLIF and naked-eye MI-TLIF in lumbar revision surgery

Clinical differences between periprosthetic and native distal femur fractures: a comparative observational study

Percutaneous monoplanar screws versus hybrid fixed axial and polyaxial screws in intermediate screw fixation for traumatic thoracolumbar burst fractures: a case–control study

Experimental assessment of pelvis slipping during postless traction for orthopaedic applications

Letter to the editor regarding: risk factors for axial symptoms following laminoplasty for cervical spondylotic myelopathy